These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 5736927)

  • 41. Survival and frequency of pulmonary metastases in rats with implanted and removed primary Yoshida sarcoma after treatment with E-aminocaproic acid and sintrom.
    Szacki J; Lawiński M; Grzebieluch M
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):763-6. PubMed ID: 4793160
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative assessment of the effect of donor blood and its components on the blood coagulation system of the recipient].
    Chistiakov VA; Belitskaia GA
    Vrach Delo; 1966 Jul; 7():39-41. PubMed ID: 5990715
    [No Abstract]   [Full Text] [Related]  

  • 43. Epsilon-aminocaproic acid therapy in cyclophosphamide-induced bladder hemorrhage. A case report.
    Covey WG
    Conn Med; 1971 Mar; 35(3):160-3. PubMed ID: 5581530
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mechanism of the hemostatic effect of epsilon-aminocaproic acid in hemoptysis in the course of lung cancer].
    Migdal A
    Wiad Lek; 1967 Mar; 20(5):419-21. PubMed ID: 6041756
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes operating in capillary resistance and permeability in atherosclerotic patients under the effect of vitamins C and P].
    Chunakova EP; Prostiakov KM; Mirer ML
    Vopr Pitan; 1966; 25(3):23-9. PubMed ID: 6003571
    [No Abstract]   [Full Text] [Related]  

  • 46. [Epsilon-aminocaproic acid in the fibrinolutic process after open heart surgery].
    García Cornejo M; Christlieb I; Barbabosa E; Corona E
    Arch Inst Cardiol Mex; 1968; 38(4):580-6. PubMed ID: 5685455
    [No Abstract]   [Full Text] [Related]  

  • 47. New anti-hemorrhagic agent, epsilon aminocaproic acid for control of hemorrhage after transurethral prostatic resection: a control study.
    Warren JW; Stanley KE
    J Kans Med Soc; 1969 Apr; 70(4):173-6. PubMed ID: 5815183
    [No Abstract]   [Full Text] [Related]  

  • 48. [The hemostatic effect of 5-aminocaproic acid].
    Shvarsalon NS; Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(6):704-7. PubMed ID: 5876372
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of therapy on the indicators of hemocoagulation and capillary resistance in patients with rheumatic heart defects].
    Mirzoian SN
    Vopr Revm; 1973; 13(2):47-51. PubMed ID: 4772874
    [No Abstract]   [Full Text] [Related]  

  • 50. [The influence of an aesculin compound preparation on blood coagulation and capillary resistance].
    Schneider J; Myrtek M
    Arztl Forsch; 1971 May; 23(5):153-9. PubMed ID: 5109595
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antihemorrhagic agent of choice in pediatric ENT: capramol Choay (epsilon-aminocaproic acid)].
    Berger M; Pinson
    J Med Bord; 1965 Apr; 142(4):719-21. PubMed ID: 5318696
    [No Abstract]   [Full Text] [Related]  

  • 52. [The value of epsilon aminocaproic acid in the dental practice].
    Deydier C; Masson CL
    Inf Dent; 1969 Jul; 51(27):2803-5. PubMed ID: 5254398
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacological research on derivatives of epsilon-aminocaproic acid. I. Action on the cardiovascular system of 3-4-5-trimethoxy-benzoyl-epsilon-aminocaproci acid].
    Razzaboni G; Setti L; Tamiso R
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1783-5. PubMed ID: 5733068
    [No Abstract]   [Full Text] [Related]  

  • 54. [Vitamin K and blood capillaries].
    Sciorelli G; Ricevuti G
    Arch Sci Med (Torino); 1974; 131(2):65-73. PubMed ID: 4417713
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunosuppressive effect and splenic changes induced by epsilon-aminocaproic acid in healthy rabbits].
    Laurentaci G; Monosi V
    Osp Ital Chir; 1967 May; 16(5):475-82. PubMed ID: 4885986
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of epsilon-aminocaproic acid in prostatic surgery].
    Lassner J
    Anesth Analg (Paris); 1965; 22(3):475-9. PubMed ID: 5847918
    [No Abstract]   [Full Text] [Related]  

  • 57. [Protective effect of sodic 3,4,5 trimethoxy-benzoyl-epsilon-amino caproate (C3) in experimental myocardial infarct. I].
    Greggia A; Baraldi M; Razzaboni G; Vergoni W
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1447-8. PubMed ID: 5397299
    [No Abstract]   [Full Text] [Related]  

  • 58. [Modification of hemorrhage after suprapubic prostatectomy with epsilon-aminocaproic acid].
    Ludvik W; Pecherstorfer M
    Wien Klin Wochenschr; 1967 May; 79(20):384-9. PubMed ID: 5589968
    [No Abstract]   [Full Text] [Related]  

  • 59. [The use of epsilon-aminocaproic acid in urology].
    Oberst O
    Z Urol Nephrol; 1965; 58(10):717-25. PubMed ID: 5866679
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental effect of E-aminocaproic acid on fetal hemorrhages].
    Linnikov VI
    Pediatr Akus Ginekol; 1980; (3):49-50. PubMed ID: 7402732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.